Structure

Physi-Chem Properties

Molecular Weight:  396.16
Volume:  403.788
LogP:  5.343
LogD:  2.535
LogS:  -3.448
# Rotatable Bonds:  2
TPSA:  100.13
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.332
Synthetic Accessibility Score:  3.807
Fsp3:  0.348
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.865
MDCK Permeability:  1.373286431771703e-05
Pgp-inhibitor:  0.603
Pgp-substrate:  0.022
Human Intestinal Absorption (HIA):  0.069
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.011

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.012
Plasma Protein Binding (PPB):  86.84906768798828%
Volume Distribution (VD):  0.925
Pgp-substrate:  13.270096778869629%

ADMET: Metabolism

CYP1A2-inhibitor:  0.411
CYP1A2-substrate:  0.437
CYP2C19-inhibitor:  0.385
CYP2C19-substrate:  0.122
CYP2C9-inhibitor:  0.766
CYP2C9-substrate:  0.64
CYP2D6-inhibitor:  0.193
CYP2D6-substrate:  0.216
CYP3A4-inhibitor:  0.11
CYP3A4-substrate:  0.172

ADMET: Excretion

Clearance (CL):  2.775
Half-life (T1/2):  0.287

ADMET: Toxicity

hERG Blockers:  0.002
Human Hepatotoxicity (H-HT):  0.784
Drug-inuced Liver Injury (DILI):  0.965
AMES Toxicity:  0.361
Rat Oral Acute Toxicity:  0.261
Maximum Recommended Daily Dose:  0.801
Skin Sensitization:  0.906
Carcinogencity:  0.382
Eye Corrosion:  0.003
Eye Irritation:  0.882
Respiratory Toxicity:  0.312

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC18100

Natural Product ID:  NPC18100
Common Name*:   Gerontoxanthone G
IUPAC Name:   4,8,9-trihydroxy-2,3,3-trimethyl-7-(3-methylbut-2-enyl)-2H-furo[3,2-b]xanthen-5-one
Synonyms:   Gerontoxanthone G
Standard InCHIKey:  IBAHQFUORXONGI-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C23H24O6/c1-10(2)6-7-12-8-13-19(25)16-14(29-22(13)21(27)18(12)24)9-15-17(20(16)26)23(4,5)11(3)28-15/h6,8-9,11,24,26-27H,7H2,1-5H3
SMILES:  CC(=CCc1cc2c(c(c1O)O)oc1c(c2=O)c(O)c2c(c1)OC(C2(C)C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL479107
PubChem CID:   14412268
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003517] 2-prenylated xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29752 Cudrania cochinchinensis n.a. n.a. n.a. roots n.a. n.a. PMID[11170668]
NPO29752 Cudrania cochinchinensis n.a. n.a. n.a. roots n.a. n.a. PMID[12932139]
NPO29752 Cudrania cochinchinensis n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO23156 Maclura cochinchinensis Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO23156 Maclura cochinchinensis Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT924 Cell Line HSC-2 Homo sapiens CC50 > 510000.0 nM PMID[521220]
NPT1273 Individual Protein ATP-dependent molecular chaperone HSP82 Candida albicans (strain WO-1) (Yeast) EC50 = 6362.0 nM PMID[521221]
NPT1397 Cell Line INS1 Rattus norvegicus AC50 = 5179.0 nM PMID[521221]
NPT27 Others Unspecified CC50 > 510000.0 nM PMID[521220]
NPT2 Others Unspecified EC50 = 6306.0 nM PMID[521221]
NPT2 Others Unspecified EC50 > 38000.0 nM PMID[521221]
NPT2 Others Unspecified EC50 = 2644.0 nM PMID[521221]
NPT2 Others Unspecified EC50 > 160000.0 nM PMID[521221]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC18100 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9935 High Similarity NPC472277
0.9871 High Similarity NPC205265
0.9871 High Similarity NPC472281
0.9747 High Similarity NPC288813
0.9744 High Similarity NPC472278
0.9744 High Similarity NPC329669
0.9744 High Similarity NPC473313
0.9618 High Similarity NPC124038
0.9563 High Similarity NPC472276
0.9557 High Similarity NPC326520
0.9557 High Similarity NPC108433
0.9557 High Similarity NPC300053
0.9557 High Similarity NPC473286
0.9554 High Similarity NPC81679
0.9551 High Similarity NPC476283
0.9551 High Similarity NPC472624
0.9548 High Similarity NPC187745
0.9548 High Similarity NPC180011
0.9548 High Similarity NPC304008
0.9548 High Similarity NPC219867
0.9548 High Similarity NPC161960
0.9548 High Similarity NPC291508
0.9545 High Similarity NPC470327
0.9545 High Similarity NPC45849
0.9545 High Similarity NPC200761
0.9545 High Similarity NPC477503
0.9497 High Similarity NPC170245
0.9497 High Similarity NPC235610
0.949 High Similarity NPC187354
0.949 High Similarity NPC134783
0.9484 High Similarity NPC291878
0.9484 High Similarity NPC195796
0.9484 High Similarity NPC115853
0.9484 High Similarity NPC209614
0.9484 High Similarity NPC470328
0.9484 High Similarity NPC35038
0.9484 High Similarity NPC278778
0.9484 High Similarity NPC472626
0.943 High Similarity NPC472635
0.9427 High Similarity NPC328102
0.9427 High Similarity NPC36217
0.9423 High Similarity NPC299520
0.9423 High Similarity NPC472598
0.9423 High Similarity NPC223787
0.9423 High Similarity NPC27337
0.9423 High Similarity NPC36852
0.9423 High Similarity NPC474055
0.9423 High Similarity NPC129684
0.9423 High Similarity NPC262286
0.9419 High Similarity NPC117992
0.9419 High Similarity NPC230149
0.9419 High Similarity NPC168247
0.9419 High Similarity NPC152951
0.9419 High Similarity NPC57674
0.9416 High Similarity NPC106976
0.9379 High Similarity NPC165456
0.9375 High Similarity NPC119589
0.9371 High Similarity NPC319200
0.9371 High Similarity NPC273959
0.9371 High Similarity NPC187491
0.9371 High Similarity NPC220313
0.9371 High Similarity NPC475985
0.9367 High Similarity NPC57715
0.9367 High Similarity NPC472275
0.9367 High Similarity NPC234644
0.9363 High Similarity NPC95936
0.9363 High Similarity NPC250214
0.9363 High Similarity NPC185258
0.9363 High Similarity NPC235448
0.9363 High Similarity NPC172770
0.9359 High Similarity NPC138243
0.9355 High Similarity NPC33051
0.9355 High Similarity NPC192083
0.9355 High Similarity NPC227337
0.9355 High Similarity NPC49402
0.9355 High Similarity NPC74924
0.9355 High Similarity NPC298692
0.9355 High Similarity NPC273462
0.9355 High Similarity NPC70433
0.9355 High Similarity NPC18727
0.9355 High Similarity NPC213896
0.9321 High Similarity NPC131866
0.9313 High Similarity NPC62261
0.9313 High Similarity NPC37183
0.9308 High Similarity NPC474034
0.9308 High Similarity NPC474033
0.9308 High Similarity NPC201800
0.9308 High Similarity NPC474150
0.9308 High Similarity NPC474162
0.9308 High Similarity NPC476247
0.9304 High Similarity NPC287328
0.9304 High Similarity NPC174953
0.9304 High Similarity NPC188433
0.9304 High Similarity NPC192686
0.9304 High Similarity NPC228785
0.9304 High Similarity NPC472631
0.9304 High Similarity NPC472630
0.9304 High Similarity NPC118256
0.9304 High Similarity NPC470326
0.9304 High Similarity NPC119209
0.9304 High Similarity NPC14353
0.9304 High Similarity NPC56085
0.9304 High Similarity NPC282009
0.9299 High Similarity NPC99597
0.9299 High Similarity NPC79053
0.9299 High Similarity NPC196448
0.9299 High Similarity NPC469584
0.9299 High Similarity NPC475267
0.9299 High Similarity NPC474208
0.9299 High Similarity NPC48208
0.9299 High Similarity NPC474836
0.9299 High Similarity NPC52889
0.9299 High Similarity NPC156057
0.9299 High Similarity NPC78225
0.9299 High Similarity NPC162869
0.9299 High Similarity NPC210084
0.9295 High Similarity NPC255807
0.9295 High Similarity NPC226025
0.9295 High Similarity NPC321779
0.9295 High Similarity NPC31018
0.9295 High Similarity NPC113906
0.9295 High Similarity NPC256925
0.929 High Similarity NPC236637
0.929 High Similarity NPC302950
0.929 High Similarity NPC257648
0.929 High Similarity NPC471982
0.929 High Similarity NPC477231
0.929 High Similarity NPC219582
0.9286 High Similarity NPC338131
0.9259 High Similarity NPC152477
0.9255 High Similarity NPC128293
0.9255 High Similarity NPC277480
0.9255 High Similarity NPC173292
0.925 High Similarity NPC306321
0.925 High Similarity NPC7483
0.925 High Similarity NPC303460
0.925 High Similarity NPC186686
0.925 High Similarity NPC41301
0.9245 High Similarity NPC471499
0.9245 High Similarity NPC474186
0.9245 High Similarity NPC278052
0.9245 High Similarity NPC474038
0.9245 High Similarity NPC40491
0.9245 High Similarity NPC472634
0.9245 High Similarity NPC26326
0.9245 High Similarity NPC472632
0.9245 High Similarity NPC266314
0.9245 High Similarity NPC32694
0.9245 High Similarity NPC471210
0.9245 High Similarity NPC61010
0.9245 High Similarity NPC471211
0.9245 High Similarity NPC471212
0.9241 High Similarity NPC210459
0.9241 High Similarity NPC85121
0.9241 High Similarity NPC100123
0.9241 High Similarity NPC204879
0.9241 High Similarity NPC55738
0.9241 High Similarity NPC473990
0.9241 High Similarity NPC22192
0.9236 High Similarity NPC472455
0.9236 High Similarity NPC472916
0.9236 High Similarity NPC68093
0.9236 High Similarity NPC235165
0.9236 High Similarity NPC191146
0.9236 High Similarity NPC255106
0.9231 High Similarity NPC469550
0.9226 High Similarity NPC31363
0.9207 High Similarity NPC310794
0.9202 High Similarity NPC279209
0.9202 High Similarity NPC102277
0.9198 High Similarity NPC117854
0.9198 High Similarity NPC477154
0.9198 High Similarity NPC6588
0.9198 High Similarity NPC247973
0.9198 High Similarity NPC150131
0.9193 High Similarity NPC475888
0.9193 High Similarity NPC293319
0.9187 High Similarity NPC83922
0.9187 High Similarity NPC472964
0.9187 High Similarity NPC472448
0.9187 High Similarity NPC220912
0.9187 High Similarity NPC470694
0.9187 High Similarity NPC211107
0.9182 High Similarity NPC45146
0.9182 High Similarity NPC320359
0.9182 High Similarity NPC472902
0.9182 High Similarity NPC475886
0.9182 High Similarity NPC474287
0.9182 High Similarity NPC299436
0.9182 High Similarity NPC321399
0.9182 High Similarity NPC476980
0.9182 High Similarity NPC475784
0.9182 High Similarity NPC235018
0.9177 High Similarity NPC165977
0.9177 High Similarity NPC473272
0.9177 High Similarity NPC284820
0.9177 High Similarity NPC241904
0.9177 High Similarity NPC472911
0.9177 High Similarity NPC52530
0.9177 High Similarity NPC245758

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC18100 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9355 High Similarity NPD2393 Clinical (unspecified phase)
0.929 High Similarity NPD1934 Approved
0.9114 High Similarity NPD3882 Suspended
0.9062 High Similarity NPD5494 Approved
0.8987 High Similarity NPD2801 Approved
0.8963 High Similarity NPD3818 Discontinued
0.8841 High Similarity NPD6167 Clinical (unspecified phase)
0.8841 High Similarity NPD6166 Phase 2
0.8841 High Similarity NPD6168 Clinical (unspecified phase)
0.8758 High Similarity NPD4868 Clinical (unspecified phase)
0.8679 High Similarity NPD4380 Phase 2
0.8654 High Similarity NPD1511 Approved
0.8631 High Similarity NPD7074 Phase 3
0.8589 High Similarity NPD7075 Discontinued
0.8571 High Similarity NPD7054 Approved
0.8544 High Similarity NPD1512 Approved
0.8521 High Similarity NPD7472 Approved
0.8519 High Similarity NPD7096 Clinical (unspecified phase)
0.8481 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8466 Intermediate Similarity NPD3817 Phase 2
0.8452 Intermediate Similarity NPD1549 Phase 2
0.8405 Intermediate Similarity NPD7819 Suspended
0.8397 Intermediate Similarity NPD2800 Approved
0.8387 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8387 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD6232 Discontinued
0.8372 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8363 Intermediate Similarity NPD6797 Phase 2
0.8354 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8353 Intermediate Similarity NPD5844 Phase 1
0.8343 Intermediate Similarity NPD7473 Discontinued
0.8323 Intermediate Similarity NPD6959 Discontinued
0.8314 Intermediate Similarity NPD6559 Discontinued
0.8314 Intermediate Similarity NPD7251 Discontinued
0.8293 Intermediate Similarity NPD1465 Phase 2
0.8266 Intermediate Similarity NPD7808 Phase 3
0.8256 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8232 Intermediate Similarity NPD6801 Discontinued
0.8221 Intermediate Similarity NPD6599 Discontinued
0.8214 Intermediate Similarity NPD1247 Approved
0.8205 Intermediate Similarity NPD2796 Approved
0.8171 Intermediate Similarity NPD7411 Suspended
0.8141 Intermediate Similarity NPD1510 Phase 2
0.814 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD2534 Approved
0.8137 Intermediate Similarity NPD2532 Approved
0.8137 Intermediate Similarity NPD2533 Approved
0.8137 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8118 Intermediate Similarity NPD3926 Phase 2
0.8095 Intermediate Similarity NPD919 Approved
0.8075 Intermediate Similarity NPD6799 Approved
0.8 Intermediate Similarity NPD943 Approved
0.8 Intermediate Similarity NPD1240 Approved
0.7988 Intermediate Similarity NPD6234 Discontinued
0.7965 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD3749 Approved
0.7917 Intermediate Similarity NPD5402 Approved
0.7898 Intermediate Similarity NPD1607 Approved
0.7888 Intermediate Similarity NPD4628 Phase 3
0.7885 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD1613 Approved
0.787 Intermediate Similarity NPD7768 Phase 2
0.7834 Intermediate Similarity NPD230 Phase 1
0.7821 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD920 Approved
0.7818 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD37 Approved
0.7796 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.779 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7228 Approved
0.7765 Intermediate Similarity NPD4965 Approved
0.7765 Intermediate Similarity NPD4967 Phase 2
0.7765 Intermediate Similarity NPD4966 Approved
0.7764 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD2935 Discontinued
0.775 Intermediate Similarity NPD6099 Approved
0.775 Intermediate Similarity NPD6100 Approved
0.7742 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD1243 Approved
0.7711 Intermediate Similarity NPD5403 Approved
0.7702 Intermediate Similarity NPD2344 Approved
0.7697 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD3027 Phase 3
0.7688 Intermediate Similarity NPD7199 Phase 2
0.7688 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD8434 Phase 2
0.7673 Intermediate Similarity NPD6651 Approved
0.7669 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD3750 Approved
0.7654 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD5710 Approved
0.7644 Intermediate Similarity NPD5711 Approved
0.7619 Intermediate Similarity NPD3226 Approved
0.761 Intermediate Similarity NPD447 Suspended
0.7609 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD2346 Discontinued
0.759 Intermediate Similarity NPD5401 Approved
0.7578 Intermediate Similarity NPD2799 Discontinued
0.7578 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD3751 Discontinued
0.7542 Intermediate Similarity NPD5953 Discontinued
0.7531 Intermediate Similarity NPD1551 Phase 2
0.753 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7528 Intermediate Similarity NPD7286 Phase 2
0.7515 Intermediate Similarity NPD2309 Approved
0.7514 Intermediate Similarity NPD8313 Approved
0.7514 Intermediate Similarity NPD8312 Approved
0.75 Intermediate Similarity NPD7685 Pre-registration
0.7485 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD1653 Approved
0.7452 Intermediate Similarity NPD9494 Approved
0.7443 Intermediate Similarity NPD3787 Discontinued
0.7425 Intermediate Similarity NPD7390 Discontinued
0.7421 Intermediate Similarity NPD2313 Discontinued
0.7421 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD6190 Approved
0.7391 Intermediate Similarity NPD1933 Approved
0.7385 Intermediate Similarity NPD8151 Discontinued
0.7381 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD3748 Approved
0.7349 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD7229 Phase 3
0.7341 Intermediate Similarity NPD5760 Phase 2
0.7341 Intermediate Similarity NPD5761 Phase 2
0.734 Intermediate Similarity NPD4363 Phase 3
0.734 Intermediate Similarity NPD4360 Phase 2
0.733 Intermediate Similarity NPD6776 Approved
0.733 Intermediate Similarity NPD6779 Approved
0.733 Intermediate Similarity NPD6780 Approved
0.733 Intermediate Similarity NPD6781 Approved
0.733 Intermediate Similarity NPD6777 Approved
0.733 Intermediate Similarity NPD6778 Approved
0.733 Intermediate Similarity NPD6782 Approved
0.731 Intermediate Similarity NPD7458 Discontinued
0.7308 Intermediate Similarity NPD7240 Approved
0.7308 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD5242 Approved
0.7299 Intermediate Similarity NPD5353 Approved
0.7297 Intermediate Similarity NPD8150 Discontinued
0.7296 Intermediate Similarity NPD4908 Phase 1
0.7292 Intermediate Similarity NPD2493 Approved
0.7292 Intermediate Similarity NPD2494 Approved
0.729 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD8127 Discontinued
0.7263 Intermediate Similarity NPD2403 Approved
0.7263 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD7907 Approved
0.7229 Intermediate Similarity NPD2424 Discontinued
0.7228 Intermediate Similarity NPD4665 Approved
0.7228 Intermediate Similarity NPD4111 Phase 1
0.7225 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD7435 Discontinued
0.7213 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD4361 Phase 2
0.7211 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD3452 Approved
0.7202 Intermediate Similarity NPD3450 Approved
0.7194 Intermediate Similarity NPD7584 Approved
0.7179 Intermediate Similarity NPD1610 Phase 2
0.7179 Intermediate Similarity NPD4583 Approved
0.7179 Intermediate Similarity NPD4582 Approved
0.7175 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD7033 Discontinued
0.7143 Intermediate Similarity NPD4110 Phase 3
0.7143 Intermediate Similarity NPD4625 Phase 3
0.7143 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6273 Approved
0.7134 Intermediate Similarity NPD9269 Phase 2
0.7128 Intermediate Similarity NPD7698 Approved
0.7128 Intermediate Similarity NPD4002 Approved
0.7128 Intermediate Similarity NPD7696 Phase 3
0.7128 Intermediate Similarity NPD7697 Approved
0.7128 Intermediate Similarity NPD4004 Approved
0.7125 Intermediate Similarity NPD2861 Phase 2
0.7107 Intermediate Similarity NPD1203 Approved
0.7104 Intermediate Similarity NPD1729 Discontinued
0.7097 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD7870 Phase 2
0.7092 Intermediate Similarity NPD7871 Phase 2
0.709 Intermediate Similarity NPD2488 Approved
0.709 Intermediate Similarity NPD2490 Approved
0.7088 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6844 Discontinued
0.7083 Intermediate Similarity NPD2973 Approved
0.7083 Intermediate Similarity NPD2654 Approved
0.7083 Intermediate Similarity NPD2974 Approved
0.7083 Intermediate Similarity NPD2975 Approved
0.7081 Intermediate Similarity NPD6832 Phase 2
0.7077 Intermediate Similarity NPD6823 Phase 2
0.7073 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD6355 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data